James Michael Brimson

19PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical devicesMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Characterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 13, 2026
Multi-Targeted Neuroprotection by Areca catechu Against Cisplatin-Induced Neurotoxicity: Cellular, Caenorhabditis elegans, and Metabolomic Evidence.

|Aug 06, 2026
Sigma-1 Receptor Ligand Blarcamesine (ANAVEX 2-73) for Alzheimer's Disease: A Systematic Review.

|Sep 18, 2025
Sigma-1 Receptor Ligands for CNS Cancer Treatment.

Anchalee Prasansuklab, Stephen T Safrany, Sirikalaya Brimson

|May 25, 2024
Role of Epigenetic Modulation in Neurodegenerative Diseases: Implications of Phytochemical Interventions.

Mani Iyer Prasanth, Bhagavathi Sundaram Sivamaruthi, Clerance Su Yee Cheong

|May 24, 2023
Virus-induced senescence: A therapeutic target to mitigate severe progression of SARS-COV-2.

Mani Iyer Prasanth, James Michael Brimson, Tewin Tencomnao

|May 11, 2023
Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders.

Dicson S Malar, Premrutai Thitilertdecha, Kanokphorn S Ruckvongacheep

Pageof 4

Frequent Collaborators

12 joint publications

Tewin Tencomnao

5 joint publications

Mani Iyer Prasanth

5 joint publications

Anchalee Prasansuklab

4 joint publications

Dicson Sheeja Malar